A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Local Institution, Odense

Columbia University, New York

University Of Rochester, Rochester

Professional Neurological Associates, Pc, Dunmore

The Clinical Trial Center Llc, Jenkintown

Local Institution, Turku

Richard H. Weisler, Md, Pa & Associates, Raleigh

Compass Research, Llc, Orlando

Md Clinical, Hallandale

Miami Research Associates, South Miami

Brain Matters Research, Delray Beach

Usf Suncoast Alzheimer'S And Gerontology Center, Tampa

Center For Clinical Trials, Venice

Meridien Research, Brooksville

University Of Alabama At Birmingham, Birmingham

Four Rivers Clinical Research, Inc, Paducah

The Ohio State University, Columbus

Neurology & Neuroscience Center Of Ohio, Toledo

Indiana University Medical Center, Indianapolis

Dean Foundation For Health Research & Education, Middleton

Local Institution, Kuopio

Tulsa Clinical Research, Llc, Tulsa

The University Of Texas, Dallas

21st Century Neurology, Phoenix

Banner Alzheimer'S Institute, Phoenix

Sun Health Research Institue, Sun City

Pacific Institute For Medical Research, Inc., Los Angeles

Mary S. Easton Center, Los Angeles

California Neuroscience Research Medical Group, Inc., Sherman Oaks

Pacific Research Network, Inc, San Diego

Collaborative Neuroscience Network, Inc., Garden Grove

Margolin Brain Institute, Fresno

Yale University School Of Medicine, New Haven

Comprehensive Psychiatric Care, Norwich

Memory Enhancement Center Of Amercia, Inc., Eatontown

Global Medical Institutes, Llc, Princeton

R.I. Mood & Memory Research Institute, East Providence

Butler Hospital, Providence

Local Institution, Malmo

Local Institution, Mölndal

Local Institution, Stockholm